Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-08 Purchase |
2020-12-08 9:04 pm |
Silverback Therapeutics Inc. | SBTX | Presidio Management Group XII L.L.C. U.S. Venture Partners XII L.P. U.S. Venture Partners XII-A L.P. Tansey Casey M 10% Owner |
47,619 | $21 | $999,999 | 47,619 (Indirect) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:56 pm |
Silverback Therapeutics Inc. | SBTX | CAPPS VICKIE L Director |
9,523 | $21 | $199,983 | 61,576 (Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:52 pm |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
238 | $21 | $4,998 | 238 (Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:50 pm |
Silverback Therapeutics Inc. | SBTX | Piazza Jonathan Chief Financial Officer |
11,904 | $21 | $249,984 | 11,904 (Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:48 pm |
Silverback Therapeutics Inc. | SBTX | Schroeder Thilo Director |
238,096 | $21 | $5,000,016 | 1,910,029 (Indirect) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:46 pm |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
95,238 | $21 | $1,999,998 | 200,250 (Indirect Direct) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:43 pm |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
1,190,477 | $21 | $25,000,017 | 1,221,700 (Indirect) |
View |
| 2020-12-08 Purchase |
2020-12-08 8:41 pm |
Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,190,477 | $21 | $25,000,017 | 1,221,700 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-12 Option Award |
2021-03-16 3:09 pm |
N/A 2031-03-11 |
Silverback Therapeutics Inc. | SBTX | Koehler Maria Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-12-08 Conversion |
2020-12-08 9:04 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Presidio Management Group XII L.L.C. U.S. Venture Partners XII L.P. U.S. Venture Partners XII-A L.P. Tansey Casey M 10% Owner |
10,246,912 | $0 | 47,619 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:48 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Schroeder Thilo Director |
7,879,822 | $0 | 1,910,029 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:46 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
10,246,912 | $0 | 200,250 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:43 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
33,046,445 | $0 | 1,221,700 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 8:41 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director 10% Owner |
33,046,445 | $0 | 1,221,700 (Indirect) |
View |
| 2020-12-08 Conversion |
2020-12-08 4:36 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Alexandria Venture Investments LLC 10% Owner |
3,296,329 | $0 | 699,412 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 8:02 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
38,270 | $0 | 38,270 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 8:01 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Odegard Valerie President and CSO |
364,904 | $0 | 364,904 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:59 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
562,631 | $0 | 562,631 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:58 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director 10% Owner |
38,270 | $0 | 38,270 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:56 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Powell Andrew Kenneth William Director |
21,009 | $0 | 21,009 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:55 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Piazza Jonathan Chief Financial Officer |
74,730 | $0 | 74,730 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:53 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Islam Saqib Director |
69,753 | $0 | 69,753 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:51 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Hunder Naomi Chief Medical Officer |
231,071 | $0 | 231,071 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:50 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | HERSHBERG ROBERT Director |
73,251 | $0 | 73,251 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:49 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
102,038 | $0 | 102,038 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 7:47 pm |
N/A 2030-12-02 |
Silverback Therapeutics Inc. | SBTX | CAPPS VICKIE L Director |
38,405 | $0 | 38,405 (Direct) |
View |
Ownership(A) |
2020-12-07 7:43 pm |
N/A 2028-12-17 |
Silverback Therapeutics Inc. | SBTX | Odegard Valerie President and CSO |
0 | $0 | 34,691 (Direct) |
View |
Ownership(A) |
2020-12-07 6:47 pm |
N/A 2030-11-04 |
Silverback Therapeutics Inc. | SBTX | Powell Andrew Kenneth William Director |
0 | $0 | 52,053 (Direct) |
View |
Ownership |
2020-12-03 9:10 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | CAPPS VICKIE L Director |
0 | $0 | 52,053 (Direct) |
View |
Ownership |
2020-12-03 9:09 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Alexandria Venture Investments LLC 10% Owner |
0 | $0 | 699,412 (Direct) |
View |
Ownership |
2020-12-03 9:09 pm |
N/A 2028-07-11 |
Silverback Therapeutics Inc. | SBTX | Odegard Valerie President and CSO |
0 | $0 | 278,843 (Direct) |
View |
Ownership |
2020-12-03 9:07 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Schroeder Thilo Director |
0 | $0 | 1,671,933 (Indirect) |
View |
Ownership |
2020-12-03 9:05 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Islam Saqib Director |
0 | $0 | 65,934 (Direct) |
View |
Ownership |
2020-12-03 9:03 pm |
N/A 2030-04-28 |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
0 | $0 | 120,628 (Direct) |
View |
Ownership |
2020-12-03 9:03 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Presidio Management Group XII L.L.C. U.S. Venture Partners XII L.P. U.S. Venture Partners XII-A L.P. Tansey Casey M 10% Owner |
0 | $0 | 2,174,179 (Indirect) |
View |
Ownership |
2020-12-03 9:01 pm |
N/A 2027-05-16 |
Silverback Therapeutics Inc. | SBTX | HERSHBERG ROBERT Director |
0 | $0 | 72,874 (Direct) |
View |
Ownership |
2020-12-03 8:59 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
0 | $0 | 7,550,411 (Indirect) |
View |
Ownership |
2020-12-03 8:57 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner |
0 | $0 | 7,550,411 (Indirect) |
View |
Ownership |
2020-12-03 8:55 pm |
N/A 2029-03-07 |
Silverback Therapeutics Inc. | SBTX | Hunder Naomi Chief Medical Officer |
0 | $0 | 196,867 (Direct) |
View |
Ownership |
2020-12-03 8:52 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
0 | $0 | 1,002,995 (Direct) |
View |
Ownership |
2020-12-03 8:50 pm |
N/A 2030-11-04 |
Silverback Therapeutics Inc. | SBTX | Piazza Jonathan Chief Financial Officer |
0 | $0 | 290,582 (Direct) |
View |
Ownership |
2020-12-03 8:46 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director 10% Owner |
0 | $0 | 2,174,179 (Indirect) |
View |